Circulating tumor cells in prostate cancer: A better predictor of survival than prostate specific antigen?

Brian Hu, Amir Goldkorn

Research output: Contribution to journalReview articlepeer-review

Original languageEnglish
Pages (from-to)1257-1260
Number of pages4
JournalExpert Review of Anticancer Therapy
Volume14
Issue number11
DOIs
StatePublished - Nov 1 2014

ASJC Scopus Subject Areas

  • Oncology
  • Pharmacology (medical)

Keywords

  • PSA
  • circulating tumor cells
  • prognosis
  • prostate cancer
  • survival

Cite this